Recombinant CCN domain proteins and fusion proteins
AssigneeOslo Universitetssykehus Hf
InventorsHåvard Attramadal, Ole Jørgen Kaasbøll
Life of this patent
Estimating the term…
Abstract
The present invention relates to recombinant proteins having an amino acid sequence corresponding to or related to the thrombospondin type 1 repeat homology domain of a member of the CCN family proteins and the use thereof. Furthermore, the present invention relates to fusion proteins comprising an amino acid sequence corresponding to or related to the thrombospondin type 1 repeat homology domain of a member of the CCN family proteins combined with a fusion partner and optionally a linker region. Also, novel protease resistant Fc-fragments are disclosed herein.
Claims18
A monomeric fusion protein comprising:
- (i) a polypeptide having 40 to 60 amino acids in length and comprising:
- (a) an amino acid sequence selected from SEQ ID NOs:
- 37 or 2 to 6;
- or (b) an amino acid sequence having at least 90% sequence identity to a sequence selected from SEQ ID NOs:
- 37 or 2 to 6;
- wherein all of the cysteine residues in said sequence selected from SEQ ID NOs:
- 37 or 2 to 6 are conserved;
- (ii) a monomeric fusion partner N- or C-terminally fused to the amino acid sequence of (i);
- and
- (iii) optionally a peptide linker between the polypeptide of (i) and the monomeric fusion partner of (ii),
- wherein the monomeric fusion partner of (ii) and the peptide linker of (iii) are not or do not comprise an IGF binding protein homology domain, a von Willebrand factor type C repeat homology domain, or a cysteine knot domain of a CCN family protein.
Dependencies are inferred from the claim text.